U.S. Logistics Stock News

Alexandria Real Estate Equities, Inc. previously declared a quarterly cash dividend of US$0.72 per common share for the March 2026 quarter, payable on July 15, 2026 to shareholders of record as of June 30, 2026. This dividend affirmation comes as the company faces concerns over weakened financial strength, debt pressures, and softer leasing and occupancy trends that raise questions about its operational resilience. We’ll now examine how heightened debt and financial distress concerns could...

Vaxcyte (PCVX) has dosed the first participant in its Phase 1 trial of VAX-A1, a Group A Strep vaccine candidate. This is a key early step in testing a product aimed at a large unmet medical need. See our latest analysis for Vaxcyte. Despite the positive development for VAX-A1, recent share price momentum has been soft, with the stock down 10.66% on a 30 day share price return and 20.16% on a 90 day share price return, while the 1 year total shareholder return of 28.03% and 5 year total...

Willis Towers Watson (WTW) has drawn fresh attention after its Dubai unit secured a DFSA licence to operate in the Dubai International Financial Centre, broadening access to regulated investment advisory and fund solutions across the Middle East. See our latest analysis for Willis Towers Watson. Alongside the DFSA approval, WTW has rolled out an AI Workforce Transformation solution, added new UK employee benefits partnerships and refreshed its North American cyber leadership team. Yet despite...

Ocular Therapeutix stock moves Ocular Therapeutix (OCUL) has been drawing attention after a stretch of weak share performance, with the stock down 6.3% on the day and declining over the past week, month, and past 3 months. See our latest analysis for Ocular Therapeutix. That weak one day share price move sits on top of a fading trend, with the 30 day share price return down 14.51%, the year to date share price return down 30.20%, and the 1 year total shareholder return down 8.54%, even though...

RenaissanceRe Holdings (RNR) is back on investor radars after recent share price swings, with the stock up 3.9% over the past day but down over the past month and the past 3 months. See our latest analysis for RenaissanceRe Holdings. Zooming out, RenaissanceRe’s recent 1-day share price gain of 3.87% to $288.48 contrasts with a weaker 30-day share price return of 3.89% and a year-to-date gain of 5.97%. At the same time, the 1-year total shareholder return of 17.59% and 5-year total...

In its recent quarterly report, 1st Source Corp. posted higher profit, raised its dividend, and increased loan loss reserves to address ongoing economic uncertainty and credit risks. An important takeaway is management’s emphasis on safety and soundness, with a proactive reserve build that may reassure investors about risk management discipline. We will now explore how the profit growth and higher dividend shape 1st Source’s broader investment narrative for current and prospective...

Earlier this week, Cardinal Health reported Q3 fiscal 2026 results that exceeded estimates and raised its full-year adjusted EPS and free cash flow guidance, alongside updates on theranostics expansion and a voluntary recall of certain alcohol prep pads. The combination of upgraded outlook and continued investment in its Center for Theranostics Advancement highlighted management’s confidence in Cardinal Health’s higher-value growth initiatives, even as the company managed operational and...

Snap (SNAP) continues to draw attention after recent trading left the stock at US$5.76, with mixed short term returns and an ongoing loss position shaping how investors assess its risk and potential reward. See our latest analysis for Snap. Recent trading has been choppy, with the 1 day share price return down 5.11% and the 30 day share price return down 5.26%. A 90 day share price return of 12.28% suggests that momentum has cooled after a stronger spring, set against a 1 year total...

In May 2026, PROCEPT BioRobotics reported two milestones in its WATER IV prostate cancer program: full enrollment of the 280‑patient randomized trial comparing Aquablation therapy with radical prostatectomy, and FDA IDE approval for a second global randomized study comparing Aquablation with active surveillance. By positioning Aquablation against both the surgical standard of care and active surveillance, PROCEPT is testing whether its robotic waterjet approach can expand treatment options...

China Yuchai International (CYD) has drawn fresh investor attention after its recent share performance, with the stock up about 23% over the past month and roughly 37% in the past 3 months. See our latest analysis for China Yuchai International. Zooming out, the 22.75% 1 month share price return and 53.32% year to date share price return sit alongside a very large 1 year total shareholder return. Momentum remains positive despite a small 1 day pullback of 2.41%. If this move has you thinking...

In early June 2026, RadNet, Inc. moved to secure a US$200 million incremental term loan maturing in 2031 to help fund acquisitions, organic expansion, health system partnerships, and other corporate purposes across its imaging network and technology platforms. This fresh borrowing push comes shortly after RadNet reported strong revenue growth but weaker-than-expected earnings, highlighting management’s focus on expansion and technology investment despite recent profit pressure. We’ll now...

Kimberly-Clark (KMB) is back in focus after stronger-than-expected earnings, reaffirmed guidance, an outlook update at a major consumer conference, and regulatory clearance for a planned international portfolio sale. See our latest analysis for Kimberly-Clark. The recent earnings beat, upbeat guidance and progress on the international portfolio sale helped lift Kimberly-Clark’s 1-day share price return by 4.84% to US$99.04, even though the 1-year total shareholder return is down 22.21%. This...

In late May 2026, Silicon Motion Technology Corporation announced the SM2524XT, a PCIe Gen5 DRAMless SSD controller built on TSMC’s 6nm process, delivering up to 14 GB/s sequential reads, up to 2.5 million IOPS random performance, and up to 25% higher performance per watt versus its previous generation. By directly targeting KV Cache and AI inference workloads with features such as Separated Command Address technology and advanced FTL scheduling, the SM2524XT positions Silicon Motion to...

O'Reilly Automotive (ORLY) expanded its share repurchase authorization by an additional US$2.0b to a total of US$31.75b and extended the program by three years, bringing capital returns back into focus for investors. See our latest analysis for O'Reilly Automotive. The buyback update comes as the stock trades at US$90.33, with a 1-day share price return of 2.18% and a 7-day share price return of 3.97%. The 1-year total shareholder return is slightly down 1.65%, while the 5-year total...

Federal National Mortgage Association (FNMA) has introduced a new Fannie Mae backed mortgage product that accepts Bitcoin as collateral for down payments, through a partnership with Coinbase and Better Mortgage. See our latest analysis for Federal National Mortgage Association. The Bitcoin backed mortgage launch comes after a period of pressure on the stock, with the share price down 14.8% over 30 days and 39.1% year to date, while the 3 year total shareholder return remains very large...

PureCycle Technologies (PCT) is back in focus after its Thailand subsidiary was admitted to the Thailand FastPass Investment Acceleration Program, tying the stock story more closely to its planned Rayong polypropylene recycling facility. See our latest analysis for PureCycle Technologies. The Thailand FastPass news lands after a sharp 112.84% 90 day share price return and a 31.32% 30 day share price return, even though the stock fell 10.29% on the day. A 26.67% 1 year total shareholder return...

NPK International (NPKI), a US based temporary worksite access solutions company, recently completed its rebrand from Newpark Resources, bringing fresh attention to a stock with mixed short term and longer term return profiles. See our latest analysis for NPK International. At a share price of US$14.28, NPK International has cooled in the very short term, with the share price down 2.33% over 1 day and 4.48% over 30 days. However, the year to date share price return of 18.02% and 1 year total...

CBL & Associates Properties (CBL) is back in focus after selling a 10.47 acre parcel near Harford Mall and lining up new retailers and restaurants at West County Center, including The Cheesecake Factory and POP MART. See our latest analysis for CBL & Associates Properties. These tenant additions and land sales sit against a solid run in the stock, with a 90-day share price return of 26.75% and a 1-year total shareholder return of 100.90%. This points to momentum that investors are watching...

Earlier this week, Sea Limited was caught in a broad selloff of high-valuation digital platforms after strong US payroll data reinforced expectations for interest rates staying higher for longer, pressuring growth-focused technology names sensitive to discount rates. This shift in macro sentiment highlights how Sea’s market value can be heavily influenced by changes in interest rate expectations, beyond its own earnings revisions and valuation debates. We’ll now examine how renewed worries...

Public Service Enterprise Group has recently completed a US$499.31 million fixed-income offering of 4.800% senior unsecured notes due June 15, 2031, priced at 99.861% of the US$500 million principal, and filed to cut New Jersey residential gas heating bills by 5% from October 1, 2026. Together, the bond issuance and planned bill reduction highlight how PSE&G is funding its capital needs while emphasizing affordability for its 1.9 million gas customers. With this planned 5% cut to residential...

Lantheus Holdings (LNTH) is back in focus after its investigational PET/CT agent LNTH-2513 (18F-GP1) earned SNMMI’s Image of the Year, tied to clinical data in acute lower-extremity deep vein thrombosis. See our latest analysis for Lantheus Holdings. The award news comes as Lantheus shares trade at US$100.98, with a 30 day share price return of 8.51% and a 90 day share price return of 26.21%. The 5 year total shareholder return is very large, suggesting momentum has been building over both...

Nuvalent, Inc. recently announced that the U.S. FDA accepted New Drug Applications for its investigational lung cancer therapies neladalkib and zidesamtinib, granting Priority Review to neladalkib and setting target action dates of September 18 and November 27, 2026, respectively. Together with the appointment of Georg Pirmin Meyer, M.D., as Chief International Officer, these milestones highlight Nuvalent’s push to build a global commercial footprint around its late-stage oncology...

Kodiak Sciences recently reported that its Phase III GLOW2 trial of Zenkuda for diabetic retinopathy met primary and key secondary endpoints with strong efficacy, and the company is also advancing multiple late-stage ophthalmology programs while maintaining a solid, debt-free balance sheet. This combination of positive late-stage data and an accelerated regulatory submission plan highlights how central Zenkuda has become to Kodiak’s overall pipeline story. Next, we’ll examine how Zenkuda’s...

Why Southwest Gas Holdings (SWX) is Back on Investor Radars Southwest Gas Holdings (SWX) has drawn fresh attention after unveiling a US$6.3 billion investment plan for 2026 to 2030, paired with higher earnings estimates and reaffirmed 2026 guidance for its regulated utility business. See our latest analysis for Southwest Gas Holdings. The reaffirmed 2026 guidance and US$6.3b investment plan come as Southwest Gas Holdings trades at US$88.72, with a year-to-date share price return of 10.69% and...